We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

190 hedge funds and large institutions have $805M invested in Immunogen Inc in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $18.4M | Put options by funds: $6.38M

9% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 57

7% less funds holding

Funds holding: 204 → 190 (-14)

20% less capital invested

Capital invested by funds: $1B → $805M (-$198M)

32% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 31

Holders
190
Holders Change
-14
Holders Change %
-6.86%
% of All Funds
3.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
62
Reduced
57
Closed
31
Calls
$18.4M
Puts
$6.38M
Net Calls
+$12M
Net Calls Change
+$8.64M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$56.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$27.8M
3
Artisan Partners
Artisan Partners
Wisconsin
+$13.6M
4
Morgan Stanley
Morgan Stanley
New York
+$13.1M
5
Millennium Management
Millennium Management
New York
+$8.71M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$31.5M
2
Jennison Associates
Jennison Associates
New York
-$29.1M
3
WP
Woodline Partners
California
-$24.9M
4
B
Braidwell
Connecticut
-$17.2M
5
GIM
Granahan Investment Management
Massachusetts
-$5.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
201
AXQ Capital
New Jersey
– -$136K -27,336 Closed
GTCM
202
Gyon Technologies Capital Management
New Jersey
– -$129K -26,077 Closed
ACM
203
Acrisure Capital Management
Texas
– -$101K -20,320 Closed
FIM
204
Freedom Investment Management
Connecticut
– -$92.3K -18,605 Closed
TL
205
Tradewinds LLC
North Carolina
– -$3.71M -16,843 Closed
GAM
206
Gotham Asset Management
New York
– -$77.7K -15,674 Closed
E
207
Ergoteles
New York
– -$77.3K -15,582 Closed
FRM
208
Fox Run Management
Connecticut
– -$60.9K -12,270 Closed
SOW
209
State of Wyoming
Wyoming
– -$24.5K -4,932 Closed
LSA
210
Leonteq Securities AG
Switzerland
– -$10.6K -2,140 Closed
NA
211
NewEdge Advisors
Louisiana
– -$7.38K -1,488 Closed
RBC
212
Roble Belko & Company
Pennsylvania
– -$5K -1,000 Closed
Rockefeller Capital Management
213
Rockefeller Capital Management
New York
– -$3K -631 Closed
LJHT
214
Laurie J. Hall Trustee
– -$2K -430 Closed
LC
215
Lindbrook Capital
California
– -$1.47K -297 Closed
CA
216
Centerpoint Advisors
Massachusetts
– -$1K -242 Closed
CT
217
Colonial Trust
South Carolina
– -$666 -129 Closed
AWM
218
Accurate Wealth Management
Florida
– -$457 -100 Closed
FGAM
219
Financial Gravity Asset Management
Texas
– -$493 -5 Closed
5 6 7 8
9

IMGN Hedge Fund Activity: Q1 2023 in Review

190 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2023, worth a combined $805M — down 20% from $1B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of IMGN and 21 opened new positions — a net loss of 10 holders — while 57 trimmed existing stakes and 62 added.

The largest buyer was Janus Henderson Group, adding an estimated $56.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $31.5M sold.

  • 190 institutional investors held Immunogen Inc (IMGN) as of Q1 2023, down from 204 in Q4 2022.
  • Funds reported $805M of Immunogen Inc stock for Q1 2023, down 20% quarter-over-quarter.
  • 21 funds opened new Immunogen Inc positions in Q1 2023 and 31 closed out, a net change of -10 holders.
  • The largest Immunogen Inc buyer in Q1 2023 was Janus Henderson Group, an estimated $56.7M added.
  • The largest Immunogen Inc seller in Q1 2023 was Deerfield Management, an estimated $31.5M sold.

Based on aggregated 13F filings for Q1 2023.